Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy
Journal
The oncologist
Journal Volume
29
Journal Issue
4
Date Issued
2024-04-04
Author(s)
Chen, Hsing-Wu
Chang, Chin-Hao
Wang, Su-Mei
Lu, Wei-Chen
Chang, Cheng-Yu
Wei, Yu-Feng
Chang, Shih-Chieh
Abstract
Reports of tuberculosis (TB) during anticancer treatment with immune checkpoint inhibitors (ICIs) are increasing. However, it is not clear whether the use of ICIs is a significant risk factor for TB, including reactivation or latent TB infection (LTBI).
Subjects
immune checkpoint inhibitors; latent tuberculosis infection; tuberculosis
Type
journal article